Literature DB >> 10966704

Arterioportal fistulas in patients with liver cirrhosis: usefulness of color Doppler US for screening.

M Bolognesi1, D Sacerdoti, G Bombonato, M Chiesura-Corona, C Merkel, A Gatta.   

Abstract

PURPOSE: To evaluate the usefulness of routine ultrasonographic (US) evaluation of the hepatic arterial resistive and pulsatility indexes and of the direction of portal venous blood flow for the diagnosis of intrahepatic arterioportal fistulas (APFs) in patients with liver cirrhosis.
MATERIALS AND METHODS: In all patients with cirrhosis examined at one center over 4 years, the resistive (RI) and the pulsatility (PI) indexes in the right and left branches of the hepatic artery were evaluated with Doppler US. An APF was suspected when an RI decrease of at least 20% and a PI decrease of at least 30% were present in one hepatic lobe relative to values in the other lobe and portal blood flow in the lobe with the decreased values was reversed. The RI and PI in patients with an APF were compared with those in 75 patients with cirrhosis and without APFs at angiography.
RESULTS: Seven patients with an APF were identified. APFs suspected at Doppler US were always confirmed with angiography. The percent differences +/- SD in the RI and the PI between the two intrahepatic branches of the hepatic artery in patients with versus in patients without an APF were as follows: RI, 35% +/- 6 (range, 27%-42%) versus 5% +/- 4 (range, 0%-15%) (P: <.001); PI, 50% +/- 5 (range, 41%-58%) versus 11% +/- 7 (range, 0%-26%) (P: <.001).
CONCLUSION: The intrahepatic arterial resistive and pulsatility indexes and the direction of portal blood flow should be evaluated in routine screening for APFs in patients with liver cirrhosis.

Entities:  

Mesh:

Year:  2000        PMID: 10966704     DOI: 10.1148/radiology.216.3.r00se20738

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

Review 1.  Portal hypertension induced by congenital hepatic arterioportal fistula: report of four clinical cases and review of the literature.

Authors:  Dan-Ying Zhang; Shu-Qiang Weng; Ling Dong; Xi-Zhong Shen; Xu-Dong Qu
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

2.  Portal Vein Thrombosis and Arterioportal Fistula in Post Liver Transplant Recipient: A Case Report.

Authors:  Shruti P Gandhi; Kajal Patel; Vaibhav Sutariya; Pranjal Modi
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  Nontumorous arterioportal shunts in the liver: CT and MRI findings considering mechanisms and fate.

Authors:  Jhii-Hyun Ahn; Jeong-Sik Yu; Sung Ho Hwang; Jae-Joon Chung; Joo Hee Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

4.  A traumatic hepatic artery pseudoaneurysm and arterioportal fistula, with severe diarrhea as the first symptom: A case report and review of the literature.

Authors:  Ping Han; Lan Yang; Xiao-Wei Huang; Xiu-Qin Zhu; Li Chen; Nan Wang; Zhen Li; De-An Tian; Hua Qin
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

5.  Endovascular treatment of hepatic arterioportal fistula complicated with giant portal vein aneurysm via percutaneous transhepatic US guided hepatic artery access: a case report and review of the literature.

Authors:  Umut Oguslu; Sadik Ahmet Uyanik; Burçak Gümüş
Journal:  CVIR Endovasc       Date:  2019-11-20

6.  Fluctuating portal velocity tracing with rhythmicity: ultrasonic differential diagnosis and clinical significance.

Authors:  Qingxin Meng; Lei Lv; Bin Yang; Ninghua Fu; Guangming Lu
Journal:  Radiol Oncol       Date:  2012-04-19       Impact factor: 2.991

7.  Endovascular treatment of portal hypertension and recurrent digestive hemorrhage secondary to arterioportal fistula syndrome: late complication of penetrating abdominal trauma.

Authors:  Matheus Bertanha; Regina Moura; Rodrigo Gibin Jaldin; Marcone Lima Sobreira; Arthur Curtarelli; Felipe Damacena Rosa; Marcelo Sembenelli; Winston Bonetti Yoshida
Journal:  J Vasc Bras       Date:  2020-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.